Volume: 8 Issue: 1
Year: 2020, Page: 4-10,
A novel Corona virus discovered during a pneumonia outbreak in Wuhan city, China has raised a global public health concern. This virus spread across the world affecting various countries and was declared a pandemic by World Health Organization(WHO). The outbreak started in December 2019 and by first week of April 2020, 212 countries were affected with more than 1million confirmed cases with a death roll of 79,235 worldwide. This disease was named as COVID-19 and the causative agent was named as Severe Acute Respiratory Syndrome Corona Virus -2 (SARS-CoV-2) due to its genetic similarity with SARS virus. SARS-CoV-2 is transmitted by respiratory droplets and by contact. Clinical symptoms include high fever, sore throat, cough, breathlessness, progress to pneumonia, acute respiratory distress and multisystem dysfunction. Infectivity rate is high with SARSCoV2 , as a result many countries are affected. Control measures like are quarantine, lockdown, regular handwashing, social distancing have been indicated by WHO and being followed by various countries. Due unavailability of an effective vaccine and specific antiviral medication against the virus, only symptomatic treatment along with the isolation of the patient is being done.
Keywords: COVID—19, SARSCoV-2, pandemic, SARS, quarantine
1. Wuhan Municipal Health Commission. Report of Clustering Pneumonia of Unknown etiology in Wuhan city, 2019. http://wjw.wuhan.gov.cn/front/web/showDetail/ 2019123108989.
2. http://www.who.int/docs/default-source/coronavirus/ situation-report/20200131-sitrep-11-ncov.pdf
3. Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel corona virus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574
4. Zhou P, yang XL, Wang XG, et al. A pneumonia outbreak associated with a new corona virus of probable bat origin. Nature.2020;579:270-273
5. Zhu N, Zhang D, Wang W, et al. a novel corona virus from patients with pneumonia in China 2019. N Engl J Med. 2020;382(8):727-733
6. https://www.who.int/emergencies/diseases/novelcoronavirus-2019
7. https://www.mygov.in/covid-19/?cbps=1
8. https://www.mohfw.gov.in/
9. He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020;1-7
10. Channappavar R, Zhao J, Perlman S. T-cell mediated immune response to respiratory corona viruses. Immunol Res 2014;59(1-3):118-128
11. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20(4):660-694
12. Chan JF, Lau SK, TO KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28(2);465-522
13. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8:S9-14
14. Middle East Respiratory Syndrome Coronavirus. https:// www.who.int/emergencies/mers-cov/en
15. Paules CI, Marston HD, Fauci AS: Coronavirus infectionsmore than just the common cold . JAMA. 2020, 323:707-708. 10.1001/jama.2020.0757
16. Richman DD, Whitley RJ,Heyden FG. Clinical Virology,4th ed. Washington:ASM Press;2016
17. Wang Q, Wong G, Lu G, Yan J, Gao GF. MERS-CoV spike protein: targets for vaccines and therapeutics. Antiviral Res.2016;133:165-177
18. Lu g, Wang Q, Gao GF. Bat-to-Human: spike features determining ‘host jump’of corona viruses SARS-CoV, MERS-CoV, and beyond. Trends microbial. 2015;23(8):468- 478
19. Li F. Structure, function and evolution of corona virus spike proteins. Annu Rev Virol. 2016;3(1):23237-261
20. He Y, Zhou Y, Liu S, et al. Receptor-binding domain of SARSCoV spike protein induces highly potent neutralizing antibodies; implication for developing subunit vaccine. Biochem Biophys res Commun. 2004;324(2):773-781
21. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS corona virus. Nature. 2003;426(6965);450-454.
22. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019 nCoV spike in the prefusion confirmation. Science. 2020;367;1260-1263
23. Luk HK, Li X, fung J, Lau SK, Woo PC. Molecular epidemiology, evolution and phylogeny of SARS corona virus. Infection, Genetics and Evolution 2019;71:21-30
24. Xinhua. China’s CDC detects a large number of new coronaviruses in the South China seafood market in Wuhan. https:// www.xinhuanet.com/2020-01/27/ c_1125504355.htm
25. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506
26. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med.2020. https://doi.org/10.1056/ NEJMoa2001316
27. https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200228-sitrep-39-covid-19.pdf
28. https://www.who.int/docs/default-source/wrindia/indiasituation-report-1.pdf? sfvrsn =5ca2a672_0
29. https://www.who.int/docs/default-source/wrindia/ situation-report/india-situation-report6606711da860b4d38b266c91265952977.pdf?sfvrsn=2f6c5c95_2
30. https://www.who.int/docs/default-source/wrindia/ situation-report/india-situation-report11.pdf?sfvrsn=438ff245_2
31. https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200412-sitrep-83-covid19.pdf?sfvrsn=697ce98d_4
32. Rothe C, Schunk M, Sothmann P, Bretzel Gisela, et al Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J M. 2020;382(10):970–971.
33. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020. 10.1056/NEJMc2001737.
34. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020 Feb 6. pii: S0195– 6701(20)30046–3.
35. Chen H, Guo J, Wang C, Luo F, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020;395(10226):809–815. doi: 10.1016/S0140- 6736(20)30360-3.
36. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211- 7.
37. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi: 10.1136/bmj.m606.
38. Cheng ZJ, Shan J. 2019 novel coronavirus: where we are and what we know. Infection. 2020:1–9. 10.1007/s15010- 020-01401-y
39. Chen F, Liu ZS, Zhang FR, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. 2020;58:E005
40. Center for Health Security. Diagnostic testing for 2019- nCoV January 28, 2020. Johns Hopkins Bloomberg School of Public Health; 2020. Available from: http://www.centerforhealthsecurity.org/resources/COVID-19/ 200130-nCoV-diagnostics-factsheet.pdf
41. World Health Organization. Guidelines for the safe transport of infectious substances and diagnostic specimens. Available from: https://www.who.int/csr/ resources/publications/biosafety/whoemc973.pdf
42. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases.
43. Corman V, Landt O, Koopmans M, Zambon M, Peiris M. Diagnostic detection of 2019-nCoV by real-time RTPCR:Protocol and primary evaluation. London: Public Health England; 2020.
44. Pang J, Wang MX, Ang IYH, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): A systematic review. J sClin Med 2020; 9 : 623.
45. Huang Peikai, Liu Tianzhu, Huang Lesheng, Liu Hailong, Lei Ming, Xu Wangdong, Hu Xiaolu, Chen Jun, Liu Bo. Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion. Radiology. 2020;295(1):22–23. doi: 10.1148/ radiol.2020200330.
46. Zhao JP, Hu Y, Du RH, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E007.
47. WHO. Clinical management of severe acute respiratory infection when novel coronavirus [nCoV] infection is suspected. Available at: https://www.who.int/ publications-detail/clinical-management-of-severe-acuterespiratory-infection-when-novelcoronavirus-[ncov]- infection-is-suspected
48. Chang D, Xu H, Rebaza A, Sharma L, Cruz CSD. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020; 8 : PE13.
49. World Health Organization. Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019- nCoV) outbreak. Geneva: WHO; 2020.s
50. Normile D. Coronavirus infections keep mounting after cruise ship fiasco in Japan. Available from: https:// www.sciencemag.org/news/2020/02/coronavirusinfections-keep-mountingafter-cruise-ship-fiasco-japan, accessed on February 28, 2020.
51. www.thelancet.com Published online March 27, 2020 https://doi.org/10.1016/S0140-6736(20)30754-6
Sri Sandhya K. SARS CoV-2. The New Pandemic: Review of Present Literature. Perspectives in Medical Research 2020; 8(1):4-10